Padraig Giles
About Padraig Giles
Padraig Giles is a Manufacturing Associate at Alkermes plc, a global biopharmaceutical company. He holds a Bachelor of Science in Biotechnology from the Institute of Technology, Sligo.
Current Role at Alkermes plc
Padraig Giles works as a Manufacturing Associate at Alkermes plc, a global biopharmaceutical company specializing in central nervous system (CNS) diseases. His role involves involvement with the company's manufacturing processes, contributing to production and quality assurance within the company's comprehensive product and clinical pipeline.
Previous Experience at Alkermes
Padraig Giles previously held the same title at Alkermes, gaining valuable experience and expertise in biopharmaceutical manufacturing processes. His work has been pivotal in maintaining the high standards required to support Alkermes' diversified commercial product portfolio and clinical pipeline targeting conditions such as schizophrenia, depression, addiction, and multiple sclerosis.
Educational Background in Biotechnology
Padraig Giles studied at the Institute of Technology, Sligo, where he earned a Bachelor of Science in Biotechnology from 2012 to 2016. This educational foundation has equipped him with the scientific knowledge and technical skills required for his current role in manufacturing within the biopharmaceutical industry.
Alkermes Manufacturing Locations
Alkermes plc, where Padraig Giles is employed, has manufacturing facilities located in Athlone, Ireland, and Wilmington, Ohio. These facilities are integral to the company’s ability to produce medications and advance its substantial clinical pipeline, including treatments for chronic diseases such as schizophrenia and multiple sclerosis.
Company Overview: Alkermes plc
Alkermes plc, headquartered in Dublin, Ireland, is a global biopharmaceutical company focused on developing medications for central nervous system diseases. The company has a diversified commercial product portfolio and a significant clinical pipeline aimed at addressing chronic conditions such as schizophrenia, depression, addiction, and multiple sclerosis. Additionally, Alkermes operates an R&D center in Waltham, Massachusetts.